| Lyso-IP: uncovering pathogenic mechanisms of lysosomal dysfunction C Chen, E Sidransky, Y Chen Biomolecules 12 (5), 616, 2022 | 9 | 2022 |
| Targeting protein clearance pathways in GBA1-associated Parkinson disease C Chen, E Hertz, Y Chen, E Sidransky Expert opinion on therapeutic targets 26 (12), 1031-1035, 2022 | 2 | 2022 |
| CRISPR/Cas9‐Based Functional Genomics in Human Induced Pluripotent Stem Cell–Derived Models: Can “the Stars Align” for Neurodegenerative Diseases? Y Chen, TTY Jong, C Chen, E Sidransky Movement Disorders 37 (5), 886-890, 2022 | 1 | 2022 |
| Generation of GBA1 isogenic iPSC lines to investigate the pathogenesis of GBA1-associated Parkinson's disease C Ma, Y Chen, C Chen, E Sidransky Molecular Genetics and Metabolism 141 (2), 107946, 2024 | | 2024 |
| Technological advances expand our knowledge of lysosomal dysfunction in neurodegeneration C Chen, Y Chen, E Sidransky Neural Regeneration Research 18 (3), 539-540, 2023 | | 2023 |
| Investigation into the pathophysiology of GBA1-associated Parkinson's disease using organelle-specific proteomics C Chen, Y Chen, R Sam, S Vrijsen, E Coccia, P Vangheluwe, T Ahfeldt, ... Molecular Genetics and Metabolism 135 (2), S29-S30, 2022 | | 2022 |
